China · Delayed Price · Currency is CNY Betta Pharmaceuticals Statistics
Total Valuation
SHE:300558 has a market cap or net worth of CNY 19.69 billion. The enterprise value is 21.47 billion.
| Market Cap | 19.69B |
| Enterprise Value | 21.47B |
Important Dates
The last earnings date was Thursday, October 29, 2026.
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | Jun 9, 2026 |
Share Statistics
SHE:300558 has 423.33 million shares outstanding. The number of shares has increased by 0.18% in one year.
| Current Share Class | 423.33M |
| Shares Outstanding | 423.33M |
| Shares Change (YoY) | +0.18% |
| Shares Change (QoQ) | -0.99% |
| Owned by Insiders (%) | 2.28% |
| Owned by Institutions (%) | 12.53% |
| Float | 241.07M |
Valuation Ratios
The trailing PE ratio is 73.57 and the forward PE ratio is 28.02.
| PE Ratio | 73.57 |
| Forward PE | 28.02 |
| PS Ratio | 5.18 |
| PB Ratio | 3.01 |
| P/TBV Ratio | 5.44 |
| P/FCF Ratio | 63.02 |
| P/OCF Ratio | 22.83 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.86, with an EV/FCF ratio of 68.71.
| EV / Earnings | 80.52 |
| EV / Sales | 5.65 |
| EV / EBITDA | 16.86 |
| EV / EBIT | 36.50 |
| EV / FCF | 68.71 |
Financial Position
The company has a current ratio of 1.00, with a Debt / Equity ratio of 0.38.
| Current Ratio | 1.00 |
| Quick Ratio | 0.66 |
| Debt / Equity | 0.38 |
| Debt / EBITDA | 1.94 |
| Debt / FCF | 7.92 |
| Interest Coverage | 8.08 |
Financial Efficiency
Return on equity (ROE) is 4.02% and return on invested capital (ROIC) is 4.33%.
| Return on Equity (ROE) | 4.02% |
| Return on Assets (ROA) | 3.69% |
| Return on Invested Capital (ROIC) | 4.33% |
| Return on Capital Employed (ROCE) | 7.22% |
| Weighted Average Cost of Capital (WACC) | 7.03% |
| Revenue Per Employee | 2.13M |
| Profits Per Employee | 149,388 |
| Employee Count | 1,785 |
| Asset Turnover | 0.38 |
| Inventory Turnover | 2.48 |
Taxes
In the past 12 months, SHE:300558 has paid 151.13 million in taxes.
| Income Tax | 151.13M |
| Effective Tax Rate | 37.60% |
Stock Price Statistics
The stock price has decreased by -18.23% in the last 52 weeks. The beta is 0.62, so SHE:300558's price volatility has been lower than the market average.
| Beta (5Y) | 0.62 |
| 52-Week Price Change | -18.23% |
| 50-Day Moving Average | 47.32 |
| 200-Day Moving Average | 50.52 |
| Relative Strength Index (RSI) | 55.31 |
| Average Volume (20 Days) | 11,725,802 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300558 had revenue of CNY 3.80 billion and earned 266.66 million in profits. Earnings per share was 0.63.
| Revenue | 3.80B |
| Gross Profit | 2.88B |
| Operating Income | 588.26M |
| Pretax Income | 401.90M |
| Net Income | 266.66M |
| EBITDA | 1.27B |
| EBIT | 588.26M |
| Earnings Per Share (EPS) | 0.63 |
Balance Sheet
The company has 706.36 million in cash and 2.47 billion in debt, with a net cash position of -1.77 billion or -4.18 per share.
| Cash & Cash Equivalents | 706.36M |
| Total Debt | 2.47B |
| Net Cash | -1.77B |
| Net Cash Per Share | -4.18 |
| Equity (Book Value) | 6.55B |
| Book Value Per Share | 15.44 |
| Working Capital | -8.56M |
Cash Flow
In the last 12 months, operating cash flow was 862.48 million and capital expenditures -550.00 million, giving a free cash flow of 312.48 million.
| Operating Cash Flow | 862.48M |
| Capital Expenditures | -550.00M |
| Depreciation & Amortization | 682.77M |
| Net Borrowing | -496,710 |
| Free Cash Flow | 312.48M |
| FCF Per Share | 0.74 |
Margins
Gross margin is 75.63%, with operating and profit margins of 15.47% and 7.01%.
| Gross Margin | 75.63% |
| Operating Margin | 15.47% |
| Pretax Margin | 10.57% |
| Profit Margin | 7.01% |
| EBITDA Margin | 33.43% |
| EBIT Margin | 15.47% |
| FCF Margin | 8.22% |
Dividends & Yields
This stock pays an annual dividend of 0.15, which amounts to a dividend yield of 0.32%.
| Dividend Per Share | 0.15 |
| Dividend Yield | 0.32% |
| Dividend Growth (YoY) | -24.60% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 47.68% |
| FCF Payout Ratio | 20.32% |
| Buyback Yield | -0.18% |
| Shareholder Yield | 0.14% |
| Earnings Yield | 1.36% |
| FCF Yield | 1.59% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SHE:300558 has an Altman Z-Score of 4.52 and a Piotroski F-Score of 7.
| Altman Z-Score | 4.52 |
| Piotroski F-Score | 7 |